Lataa...
Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy
Macrophage inhibitory factor 1 (MIC1) is frequently altered in various cancers. The aim of this study was to investigate the clinical significance of MIC1 for esophageal squamous cell carcinoma (ESCC). Serum MIC1 of 286 ESCC and 250 healthy subjects was detected, the diagnostic performance was asses...
Tallennettuna:
| Julkaisussa: | Cancer Sci |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Blackwell Publishing Ltd
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4317821/ https://ncbi.nlm.nih.gov/pubmed/24383865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12331 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|